Stay updated on RO6874281 for HER2-positive Cancer: Clinical Trial
Sign up to get notified when there's something new on the RO6874281 for HER2-positive Cancer: Clinical Trial page.

Latest updates to the RO6874281 for HER2-positive Cancer: Clinical Trial page
- Check2 days agoChange DetectedThis version shows deletions of major sections—status, recruitment, study design, eligibility, arms/interventions, outcome measures, and locations/contacts—resulting in a leaner display of the trial's history.SummaryDifference15%

- Check9 days agoChange DetectedRecruitment status now shows no longer looking for participants, indicating the study is no longer enrolling. The revision history is updated to v3.6.0, and the previous v3.5.5 label is removed.SummaryDifference0.2%

- Check16 days agoChange DetectedThe revision history now includes a new entry for v3.5.5 and removes the previous v3.5.4, reflecting an update to the recorded versions of the study record.SummaryDifference0.0%

- Check38 days agoChange DetectedA new revision entry (v3.5.4) was added to the record history, and the previous revision (v3.5.3) was removed from the current change list. This update pertains to the history metadata rather than the study content.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page’s displayed application/site revision version was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check66 days agoChange DetectedAdded revision: v3.5.2; removed revision: v3.5.0 from the history.SummaryDifference0.0%

Stay in the know with updates to RO6874281 for HER2-positive Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RO6874281 for HER2-positive Cancer: Clinical Trial page.